Your browser doesn't support javascript.
loading
Effectiveness and safety of sofosbuvir plus ribavirin for HCV genotype 2 patients 65 and over with or without cirrhosis.
Ogawa, Eiichi; Furusyo, Norihiro; Nomura, Hideyuki; Takahashi, Kazuhiro; Higashi, Nobuhiko; Kawano, Akira; Dohmen, Kazufumi; Satoh, Takeaki; Azuma, Koichi; Nakamuta, Makoto; Koyanagi, Toshimasa; Kato, Masaki; Shimoda, Shinji; Kajiwara, Eiji; Hayashi, Jun.
Afiliação
  • Ogawa E; Department of General Internal Medicine, Kyushu University Hospital, Fukuoka, Japan.
  • Furusyo N; Department of General Internal Medicine, Kyushu University Hospital, Fukuoka, Japan.
  • Nomura H; The Center for Liver Disease, Shin-Kokura Hospital, Kitakyushu, Japan.
  • Takahashi K; Department of Medicine, Hamanomachi Hospital, Fukuoka, Japan.
  • Higashi N; Department of Hepatology, Steel Memorial Yawata Hospital, Kitakyushu, Japan.
  • Kawano A; Department of Medicine, Kitakyushu Municipal Medical Center, Kitakyushu, Japan.
  • Dohmen K; Department of Internal Medicine, Chihaya Hospital, Fukuoka, Japan.
  • Satoh T; Center for Liver Disease, National Hospital Organization Kokura Medical Center, Kitakyushu, Japan.
  • Azuma K; Department of Medicine, Kyushu Central Hospital, Fukuoka, Japan.
  • Nakamuta M; Department of Gastroenterology, Kyushu Medical Center, National Hospital Organization, Fukuoka, Japan.
  • Koyanagi T; Department of Medicine, Fukuoka City Hospital, Fukuoka, Japan.
  • Kato M; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Shimoda S; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Kajiwara E; Kajiwara Clinic, Kitakyushu, Japan.
  • Hayashi J; Kyushu General Internal Medicine Center, Haradoi Hospital, Fukuoka, Japan. Electronic address: hayashij1949@haradoi-hospital.com.
Antiviral Res ; 136: 37-44, 2016 12.
Article em En | MEDLINE | ID: mdl-27789224

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Ribavirina / Hepacivirus / Hepatite C Crônica / Sofosbuvir / Cirrose Hepática Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Antiviral Res Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Ribavirina / Hepacivirus / Hepatite C Crônica / Sofosbuvir / Cirrose Hepática Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Antiviral Res Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão País de publicação: Holanda